in-stent restenosis

Clinical Images

An Impressive Case of Honeycomb In-Stent Restenosis

08/28/2018

Giovanni Lorenzoni, MD; Pierluigi Merella, MD; Graziana Viola, MD; Nicola Marziliano, PhD; Gavino Casu, MD

Giovanni Lorenzoni, MD; Pierluigi Me...

This image shows an impressive “honeycomb” pattern of neoatherosclerosis in the context of very late in-stent restenosis. In this case, OCT excluded the most common mechanisms of late in-stent restenosis, underlying the complexity of this...

This image shows an impressive...

08/28/2018

Journal of Invasive Cardiology

Editor's Corner

Pitfalls and New Options for Treatment of Femoral and Popliteal In-Stent Restenosis

08/30/2016

In-stent restenosis is a growing clinical challenge, and repeat interventions are costly and carry risks. There are new devices available that could, in combination with other therapies, reduce cost and improve results for in-stent restenosis...

In-stent restenosis is a growing...

08/30/2016

Vascular Disease Management

Role of Nitinol Stent Fractures in the Development of In-Stent Restenosis in the Superficial Femoral Artery

12/30/2015

Anvar Babaev, MD, PhD; Pawan Hari, MD; Susanna Zavlunova, MD; Anna Kurayev, MD

New York University Langone Medical Center, New York, New York

Anvar Babaev, MD, PhD; Pawan Hari, MD...

Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.

Stent fractures in the SFA play...

12/30/2015

Vascular Disease Management

Demystifying Stent Fractures: One Step Closer to Decoding the In-Stent Restenosis Conundrum

12/30/2015

Amjad AlMahameed, MD, MPH; Craig Walker, MD

Cardiovascular Institute of the South, Houma, Louisiana

Amjad AlMahameed, MD, MPH; Craig Walk...

Despite new technologies and research, stent fracture continues to be a challenge faced by vascular specialists.

Despite new technologies and...

12/30/2015

Vascular Disease Management

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

08/29/2015

Osamu Iida, MD

Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan

Osamu Iida, MD Kansai Rosai Hospi...

Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...

Although endovascular therapy of...

08/29/2015

Vascular Disease Management

Interventional Treatment of Superficial Femoral Artery In-Stent Restenosis

07/01/2015

Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.

Treatment of in-stent restenosis...

07/01/2015

Vascular Disease Management

Craig Walker, MD, Discusses 12-Month Data From EXCITE ISR

07/01/2015

Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...

Dr. Walker, an interventional...

07/01/2015

Vascular Disease Management